Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study
厄达替尼或厄达替尼联合西曲利单抗治疗伴有FGFR改变的转移性尿路上皮癌患者:II期NORSE研究的最终结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00826
Loriot, Yohann; Powles, Thomas; Moreno, Victor; Kang, Taek Won; Cicin, Irfan; Girvin, Angela; Akapame, Sydney; O'Hagan, Anne; Zhu, Wei; Tammaro, Meggan; Thomas, Shibu; Triantos, Spyros; Siefker-Radtke, Arlene O